Immediate Impact
27 standout
Citing Papers
Extracellular matrix remodeling in the tumor immunity
2024 Standout
The Interplay between Extracellular Matrix Remodeling and Cancer Therapeutics
2024 Standout
Works of Montse Muñoz being referenced
A phase I study of the SRC kinase inhibitor dasatinib with trastuzumab and paclitaxel as first line therapy for patients with HER2-overexpressing advanced breast cancer. GEICAM/2010-04 study
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Montse Muñoz | 48 | 16 | 29 | 21 | 6 | 90 | |
| Supriya Jain | 32 | 19 | 35 | 47 | 8 | 124 | |
| Christopher K Bruce | 44 | 6 | 8 | 49 | 6 | 198 | |
| Helena Champion | 66 | 21 | 72 | 11 | 9 | 186 | |
| Kate Anderton | 34 | 7 | 32 | 117 | 8 | 187 | |
| Constantina Mateoiu | 26 | 10 | 19 | 37 | 8 | 85 | |
| Leonardo Forero | 62 | 20 | 10 | 44 | 6 | 109 | |
| Andrea Lindgren | 41 | 4 | 49 | 41 | 11 | 164 | |
| Shruti Tiwari | 64 | 19 | 17 | 23 | 10 | 100 | |
| Glen J. Weiss | 73 | 4 | 11 | 57 | 9 | 138 | |
| Samer S. Kasbari | 81 | 3 | 41 | 28 | 6 | 198 |
All Works
Loading papers...